- Home
- Equipment
- usa massachusetts
- pancreas
Show results for
Refine by
Applications
Pancreas Equipment Supplied In Usa Massachusetts
16 equipment items found
Manufactured by:Beta Bionics, Inc. based inConcord, MASSACHUSETTS (USA)
Long story short, we’re a medical device company currently focused on the design, development, and launch of an insulin delivery device - the iLet® Bionic Pancreas. CAUTION: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. To be clear, the iLet Bionic ...
Manufactured by:BK Medical Holding Company, Inc. based inBurlington, MASSACHUSETTS (USA)
The I12C5 is a high-resolution finger transducer designed for intraoperative imaging of the pancreas, liver, and ...
by:Vertex Pharmaceuticals based inBoston, MASSACHUSETTS (USA)
Cystic fibrosis (CF) is a rare, chronic and life-shortening genetic disease. It’s a progressive, multi-system disease that affects the lungs, liver, gastrointestinal tract, pancreas, sinuses, sweat glands and reproductive tract. In the lungs, this leads to the buildup of abnormally thick, sticky mucus that can cause chronic lung infections and inflammation, resulting in ...
Manufactured by:Union Biometrica, Inc. based inHolliston, MASSACHUSETTS (USA)
The COPAS FP-250 instrument features our smallest flow cell available (250 µm) and is ideal for use with all stages of C.elegans as well as cell clusters like mouse adipocytes, ESC’s / EB’s, hepatocytes, pancreatic islets, and duct cells as well as small beads and seeds with sizes from 20 to 200 microns (diameter). Although the FP-500 can also be used for sorting C. elegans, the ...
Manufactured by:Union Biometrica, Inc. based inHolliston, MASSACHUSETTS (USA)
The COPAS FP-250 instrument features our smallest flow cell available (250 µm) and is ideal for use with all stages of C.elegans as well as cell clusters like mouse adipocytes, ESC’s / EB’s, hepatocytes, pancreatic islets, and duct cells as well as small beads and seeds with sizes from 20 to 200 microns (diameter). Although the FP-500 can also be used for sorting C. elegans, the ...
Manufactured by:AVEO Pharmaceuticals, Inc. based inBoston, MASSACHUSETTS (USA)
AV-203 (CAN017) is a clinical-stage ErbB3 (HER3) inhibitory antibody candidate designed to inhibit both ligand-dependent and ligand-independent ErbB3 signaling. ErbB3 is a receptor that is typically expressed in many human cancers, and AV-203 has demonstrated preclinical activity in a number of different tumor models including breast, head and neck, lung, ovarian and pancreatic ...
Manufactured by:Universal Diagnostics SL based inSeville, SPAIN
We are developing Signal-X, a multi-cancer platform able to detect various types of high-burden cancers with high sensitivity and tissue-of-origin specificity. ...
Manufactured by:Transgene based inIllkirch-Graffenstaden, FRANCE
A new generation of multifunctional oncolytic virus, TG6002 has been designed to combine the mechanism of oncolysis (targeted destruction of the cancer cell) with the production of chemotherapy (5-FU), directly into the ...
Manufactured by:AVEO Pharmaceuticals, Inc. based inBoston, MASSACHUSETTS (USA)
Ficlatuzumab (formerly known as AV-299) is a potent hepatocyte growth factor (HGF) immunoglobulin G1 (IgG1) inhibitory antibody that binds to the HGF ligand with high affinity and specificity. HGF is the natural ligand of c-Met and blocking HGF inhibits signaling through the HGF/c-Met signaling ...
by:Huabio based inWoburn, MASSACHUSETTS (USA)
Western blot analysis of GARS on Raji cell lysates. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody (ET1610-67, 1/500) was used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:40,000 dilution was used for 1 hour at room ...
Manufactured by:LifeSpan BioSciences, Inc based inShirley, MASSACHUSETTS (USA)
LTB4R2 is a low-affinity receptor for leukotrienes including leukotriene B4. It mediates the chemotaxis of granulocytes and macrophages. The response is mediated via G-proteins that activate a phosphatidylinositol-calcium second messenger system. The rank order of affinities for the leukotrienes is LTB4 > 12-epi-LTB4 > LTB5 > LTB3. LTB4R2 has been found to be overexpressed in esophageal ...
Manufactured by:Alphageneron based inCambridge, MASSACHUSETTS (USA)
An allogenic NK cell therapy that targets tumors expressing mHsp70. Patients are selected with high mHsp70 exosomes in their blood using our Companion Diagnostic AP-CDx (described below). We obtain PBMCs from healthy donors by apheresis, their NK cells are expanded, and incubated ex vivo with TKD and IL-2, followed by freezing, thawing and intravenous administration to ...
Manufactured by:GI Dynamics, Inc. based inBoston, MASSACHUSETTS (USA)
EndoBarrier is an endoscopically delivered medical device intended to help restore healthy blood sugar levels and reduce weight. EndoBarrier is an investigational medical device for people living with uncontrolled type 2 diabetes and obesity that is sought to bridge the gap between partially effective medications, insulin injections, and irreversible ...
Manufactured by:Fractyl Health based inLexington, MASSACHUSETTS (USA)
Our lead product candidate, the Revita DMR System, or Revita®, is a first-in-class procedural therapy designed to target the duodenum as a root cause of type 2 diabetes. For people with advanced type 2 diabetes, the main form of therapy to control HbA1c today is insulin dose escalation and lifestyle interventions. We have developed and are investigating Revita DMR with the goal of providing ...
Manufactured by:Elicio Therapeutics based inBoston, MASSACHUSETTS (USA)
Our lymph node-targeted mKRAS cancer vaccine; Our Amphiphile (AMP)-powered lead candidate, ELI-002, generates a robust immune response against mutant Kristen rat sarcoma (mKRAS), with the potential to offer patients a stronger fight against the most aggressive cancers. Preliminary data have shown that ELI-002 produces a potent mKRAS-specific T-cell response, including both CD4+ and CD8+ ...
by:Aphios Corporation based inWoburn, MASSACHUSETTS (USA)
Prostate cancer is the most prevalent cancer among men, and it is the second leading cause of cancer death among men in the United States. More than 500,000 cases are diagnosed annually. In the U.S. this year, 1 in 6 males will develop the disease and 30,000 others will die of it. Although prostate cancer mostly affects elderly men, the number of younger men with prostatic carcinoma is ...